Live Analyst Rating Changes 23633 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David Risinger
LP

David Risinger

Leerink Partners
Wall Street Analyst
★★★★☆
#776
on 13Foresight · ranked by our own returns
68%
Success Rate
+18.5%
Average Return
34 of 50 calls profitable · +4.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 68% of David Risinger's ratings turned a profit when each position was held for 1 year — averaging +18.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

75 Buy 21 Hold 1 Sell
David's Stock Coverage 43 ratings · 2026-08-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
TENX
Tenax Therapeutics
 Aug 11, 2026 BUY Strong Buy
+1504.9% avg upside
9 analysts
$4.00
146.86% Upside
 +6.2% ·
HALO
Halozyme
 Aug 07, 2026 BUY Strong Buy
-36.6% avg upside
20 analysts
$110.00
7.26% Upside
 -1.3% ·
JNJ
Johnson & Johnson
 Jul 17, 2026 BUY Strong Buy
-9.2% avg upside
39 analysts
$276.00
6.32% Upside
 +2.6% ·
LLY
Eli Lilly & Co
 Jul 17, 2026 BUY Strong Buy
-13.8% avg upside
48 analysts
 — +3.5% ·
ORKA
Oruka Therapeutics
 Jun 02, 2026 BUY Strong Buy
+20.5% avg upside
16 analysts
 — +89.5% ·
ANAB
AnaptysBio
 May 27, 2026 BUY Strong Buy
+26.8% avg upside
26 analysts
 — -0.5% ·
REGN
Regeneron
 May 18, 2026 HOLD Strong Buy
-2.1% avg upside
58 analysts
$641.00
19.61% Downside
 +26.9% ·
IMA
ImageneBio
 May 08, 2026 BUY Buy
+199.0% avg upside
12 analysts
$24.00
327.74% Upside
 +6.0% ·
TRAX
First Tracks Biotherapeutics Inc
 Apr 24, 2026 BUY Strong Buy
+6.8% avg upside
8 analysts
$46.00
1.55% Downside
 +149.6% ·
AMGN
Amgen
 Jan 13, 2026 HOLD Buy
-23.9% avg upside
57 analysts
 — +30.5% ·
ABBV
AbbVie
 Jan 13, 2026 BUY Strong Buy
-4.3% avg upside
46 analysts
 — +15.3% ·
BMY
Bristol-Myers Squibb
 Jan 13, 2026 BUY Buy
-4.4% avg upside
42 analysts
$60.00
5.63% Downside
 +18.5% ·
VRTX
Vertex Pharmaceuticals
 Dec 29, 2025 BUY Strong Buy
-15.5% avg upside
62 analysts
$525.00
0.97% Downside
 +14.3% ·
FR:SAN
Sanofi
 Dec 24, 2025 BUY Strong Buy
+30.0% avg upside
30 analysts
 — -4.6% ·
ROIV
Roivant Sciences
 Dec 15, 2025 BUY Strong Buy
+0.7% avg upside
17 analysts
$32.00
9.32% Downside
 +65.1% ·
PFE
Pfizer
 Dec 09, 2025 HOLD Buy
+25.8% avg upside
45 analysts
$26.00
2.34% Downside
 +12.3% ·
PCVX
Vaxcyte
 Oct 01, 2025 BUY Strong Buy
+75.9% avg upside
15 analysts
 — +56.7% ·
SNY
Sanofi
 Sep 04, 2025 BUY Strong Buy
+69.5% avg upside
20 analysts
 — +1.9% ·
TECX
Tectonic Therapeutic
 Sep 01, 2025 BUY Strong Buy
+75.7% avg upside
24 analysts
 — +121.2% ·
SVRN
OceanPal Inc
 Aug 17, 2025 BUY Buy
6 analysts
 — -86.7% ·
TBPH
Theravance Biopharma
 Aug 13, 2025 HOLD Buy
+9.0% avg upside
18 analysts
$13.00
23.14% Downside
 +36.4% ·
GPCR
Structure Therapeutics, Inc. Sponsored ADR
 Aug 07, 2025 BUY Strong Buy
+98.6% avg upside
17 analysts
$44.00
15.57% Downside
 +228.0% ·
MRNA
Moderna
 Apr 16, 2025 SELL Hold
+17.8% avg upside
38 analysts
$23.00
61.97% Downside
 -117.1% ·
MP
MP Materials
 Feb 24, 2025 BUY Strong Buy
+16.1% avg upside
22 analysts
$28.00
49.26% Downside
 +140.8% ·
IRWD
Ironwood Pharma
 Jan 17, 2025 HOLD Buy
+178.5% avg upside
23 analysts
 — +22.9% ·
CABO
Cable ONE
 May 01, 2024 BUY Hold
+1339.5% avg upside
9 analysts
 — -31.7% ·
GILD
Gilead Sciences
 Apr 28, 2023 HOLD Strong Buy
-12.1% avg upside
66 analysts
$91.00
32.99% Downside
 -17.3% ·
PAX
Patria Investments
 Mar 14, 2023 BUY Buy
+41.1% avg upside
7 analysts
 — +6.1% ·
OGN
Organon
 Jun 11, 2021 HOLD Sell
+8.9% avg upside
9 analysts
$33.00
141.75% Upside
 +23.6% ·
JAZZ
Jazz Pharmaceuticals
 May 21, 2021 HOLD Strong Buy
-5.0% avg upside
35 analysts
$176.00
29.01% Downside
 -17.5% ·
PAHC
Phibro Animal Health
 May 13, 2021 SELL Sell
+8.9% avg upside
10 analysts
$22.00
35.51% Downside
 +31.4% ·
MRK
Merck & Company
 Apr 01, 2021 BUY Strong Buy
-0.7% avg upside
43 analysts
$90.00
30.90% Downside
 +17.7% ·
VTRS
Viatris
 Mar 10, 2021 HOLD Buy
+44.1% avg upside
21 analysts
$16.00
1.81% Downside
 -25.7% ·
PRGO
Perrigo Company
 Mar 05, 2021 HOLD Buy
+431.9% avg upside
20 analysts
$45.00
250.11% Upside
 -6.4% ·
TSE:BHC
Bausch Health Companies
 Feb 26, 2021 HOLD Buy
+568.6% avg upside
29 analysts
$48.77
461.75% Upside
 -22.8% ·
TEVA
Teva Pharmaceutical
 Dec 21, 2020 SELL Buy
-17.3% avg upside
39 analysts
$9.00
75.26% Downside
 +14.9% ·
ALKS
Alkermes
 Dec 21, 2020 HOLD Strong Buy
-15.7% avg upside
34 analysts
$22.00
55.23% Downside
 +8.1% ·
ELAN
Elanco Animal Health
 Nov 23, 2020 BUY Strong Buy
+38.0% avg upside
18 analysts
$41.00
80.46% Upside
 +3.4% ·
ZTS
Zoetis
 Nov 13, 2020 HOLD Buy
+59.1% avg upside
23 analysts
$174.00
130.94% Upside
 +31.5% ·
RPRX
Royalty Pharma
 Jul 13, 2020 HOLD Strong Buy
+0.5% avg upside
15 analysts
$51.00
11.65% Downside
 -3.7% ·
AMRX
Amneal Pharmaceuticals
 Apr 02, 2020 HOLD Strong Buy
+3.6% avg upside
18 analysts
$3.00
82.36% Downside
 +116.4% ·
COR
Cencora
 Nov 16, 2015 HOLD Buy
-3.4% avg upside
44 analysts
 — -17.9% ·
ORCL
Oracle
 Sep 21, 2012 BUY Strong Buy
+50.7% avg upside
70 analysts
$36.00
75.24% Downside
 +6.0% ·
🔒 38 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David Risinger — Frequently Asked Questions
How accurate are David Risinger's stock ratings?
Based on the calls 13Foresight could measure, about 69% of David's ratings were profitable over a one-year hold, with an average return of +22.4% per rating, or +7.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is David ranked on 13Foresight?
David Risinger is currently ranked #776 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on TENX, HALO, JNJ, LLY, ORKA, ANAB, REGN, IMA, TRAX, AMGN, ABBV, BMY and 31 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.